Skip to main content
. 2020 Sep 23;10:15567. doi: 10.1038/s41598-020-72649-5

Figure 2.

Figure 2

(A) Pooled incidence of treatment-related adverse events and immune-related adverse events among the 1063 patients; (B) Toxicity profiles in the 1063 patients.